Found 75 matching trials
A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen
PHASE2This is a single arm, open label Phase II clinical trial to evaluate the ef...
The Mass Balance and Biotransformation of [14C]Donafenib in Healthy Adult Man
PHASE1This study was designed to evaluate the mass balance and biotransformation ...
Location
The First Affiliated Hospital of Suzhou University
Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer
PHASE1The goal of this clinical trial is to evaluate the efficacy and safety of c...
Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH)
Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab
PHASE2This is a multi-center, single arm study to evaluate the efficacy and safet...
Location
No.2 People's Hospital of Fuyang city
Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer
PHASE1The investigators do the clinical trial (patients with metastatic colorecta...
Location
West China Hospital,SCU
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
N/AThis study is conducted to evaluate the efficacy, prognosis, adverse effect...
Location
The Second Affiliated Hospital of Fujian Medical University
Donafenib and Toripalimab Combined With TACE in Patients With Unresectable Hepatocellular Carcinoma
PHASE1This study is the single-center, open-label phase I clinical trial to evalu...
Location
Hunan Cancer Hospital
Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis
PHASE4For HCC patients with combined PVTT, systemic therapy can be used as a basi...
Location
Multiple Locations
HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC
N/AThe purpose of this study is to evaluate the safety and efficacy of hepatic...
Status
Active Not Recruiting
Location
The first hospital of China medical university
Donafenib Plus Sintilimab in Combination With TACE in Patients With Unresectable Hepatocellular Carcinoma
PHASE2To evaluate the efficacy and safety of Donafenib plus Sintilimab in combina...
Status
Active Not Recruiting
Location
Nanfang Hospital, Southern Medical University